EM-T3Therapeutics and Clinical Risk Management2018-05-01第 Volume 14 卷，833-847综述开放获取
Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
